Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Volinanserin (MDL100907) 是选择性的5-HT2受体拮抗剂,Ki 值为 0.36 nM,可用于精神疾病的研究。它对 5-HT2 受体的选择性比 5-HT1c、α-1 肾上腺素能受体和 σ 受体高 300 倍。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 912 | 现货 | ||
10 mg | ¥ 1,460 | 现货 | ||
25 mg | ¥ 2,900 | 现货 | ||
50 mg | ¥ 3,780 | 现货 | ||
200 mg | ¥ 7,630 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 996 | 现货 |
产品描述 | Volinanserin (MDL100907) (MDL 100907) is a potent and selective antagonist of the serotonin receptor 5-HT2 (Ki: 0.36 nM) and shows 300-fold selectivity for 5-HT2 receptor over 5-HT1c, alpha-1 adrenergic and sigma receptors. |
靶点活性 | 5-HT2 receptor:0.36 nM (Ki) |
体外活性 | MDL 100,907 demonstrated low nanomolar or subnanomolar binding in vitro at the 5-HT2A receptor and showed a > 100-fold separation from all other receptors measured. MDL 100,907 had subnanomolar potency as a 5-HT2A antagonist in vitro in reversing 5-HT-stimulated inositol phosphate accumulation in NIH 3T3 cells transfected with the rat 5-HT2A receptor [2]. |
体内活性 | In mice, MDL 100,907 blocked amphetamine-stimulated locomotion at doses that did not significantly affect apomorphine-stimulated climbing behavior. When administered chronically, MDL 100,907 selectively reduced the number of spontaneously active A10 neurons [1]. In vivo, MDL 100,907 potently inhibited 5-methoxy-N, N-dimethyltryptamine-induced head twitches in mice or 5-hydroxytryptophan-induced head twitches in rats. In vivo, functional tests in mice revealed a > 500-fold separation between doses that produced 5-HT2A antagonism and doses that produced alpha 1-adrenergic or striatal D2 antagonism [2]. |
别名 | M 100907, MDL100907, 氟利色林 |
分子量 | 373.46 |
分子式 | C22H28FNO3 |
CAS No. | 139290-65-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (267.8 mM)
Ethanol: 18 mg/mL (48.2 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 2.6777 mL | 13.3883 mL | 26.7766 mL | 66.9416 mL |
5 mM | 0.5355 mL | 2.6777 mL | 5.3553 mL | 13.3883 mL | |
10 mM | 0.2678 mL | 1.3388 mL | 2.6777 mL | 6.6942 mL | |
20 mM | 0.1339 mL | 0.6694 mL | 1.3388 mL | 3.3471 mL | |
DMSO | 50 mM | 0.0536 mL | 0.2678 mL | 0.5355 mL | 1.3388 mL |
100 mM | 0.0268 mL | 0.1339 mL | 0.2678 mL | 0.6694 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Volinanserin 139290-65-6 GPCR/G Protein Neuroscience 5-HT Receptor M100907 M 100907 Serotonin Receptor inhibit MDL100907 5-hydroxytryptamine Receptor Inhibitor MDL-100907 M-100907 MDL 100907 氟利色林 inhibitor